Therefore, we conclude that supplementation with palmitoleic acid but not with oleic acid can attenuate insulin resistance, liver damage, and inflammation induced by a HFD via mechanisms that do not depend on PPARα. The gene discussed is PPARA; the disease is Insulin resistance.